Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
0.00Prev. Close
0.00Volume
NATotal traded value
NAUpper Circuit
NALower Circuit
NAFundamentals
| Market Cap | ₹103Cr |
| ROE | 5.87% |
| P/E Ratio(TTM) | 27.30 |
| EPS(TTM) | 31.43 |
| P/B Ratio | 1.92 |
| Dividend Yield | 0.41% |
| Industry P/E | 40.02 |
| Book Value | 446.41 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Mercury Labs
Mercury Laboratories is a leading pharmaceutical company specializing in developing high-quality medicines and is dedicated to Mother & Child Healthcare. The company's mission is to improve patients' quality of life by providing safe, effective, and accessible medicines to the communities it serves. From its manufacturing units in Vadodara, the company successfully exports its products to over 40 countries across the globe.;
| Parent Organisation | Mercury Labs Limited |
| Managing Director | Mr. Rajendra Shah |
| BSE Symbol | 538964 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.56 | ||
| Ajanta Pharma | NA (0.00%) | 34.44 | ||
| Gland Pharma | NA (0.00%) | 41.06 | ||
| Eris Lifesciences | NA (0.00%) | 60.18 |